ACH · Insider Trading
Accendra Health, Inc.
Every open-market purchase and sale reported by ACH officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-06 | Kenneth Gardner-Smith | President & CEO | A | +283,554 | — |
| 2026-09-24 | Jonathan A Leon | EVP & CFO | F | −4,265 | −$3.63K |
| 2026-05-20 | Heath H Galloway | EVP,General Counsel & CorpSecy | F | −1,822 | −$5.30K |
| 2026-05-19 | Edward A Pesicka | President & CEO | F | −17,692 | −$53.78K |
| 2026-05-19 | Jonathan A Leon | EVP & CFO | F | −1,770 | −$5.38K |
| 2026-05-19 | Perry A Bernocchi | EVP, Chief Operating Officer | F | −7,908 | −$24.04K |
| 2026-05-19 | Heath H Galloway | EVP,General Counsel & CorpSecy | F | −966 | −$2.94K |
| 2026-05-18 | Mark A Beck | Director | A | +31,191 | — |
| 2026-05-18 | Kenneth Gardner-Smith | Director | A | +31,191 | — |
| 2026-05-18 | Gwendolyn M Bingham | Director | A | +31,191 deriv. | — |
| 2026-05-18 | Teresa L. Kline | Director | A | +31,191 | — |
| 2026-05-18 | Stephen W Klemash | Director | A | +31,191 | — |
| 2026-03-24 | Jonathan A Leon | EVP & CFO | F | −11,286 | −$22.91K |
| 2026-03-24 | Edward A Pesicka | President & CEO | F | −58,945 | −$119.66K |
| 2026-03-24 | Perry A Bernocchi | EVP, Chief Operating Officer | F | −20,841 | −$42.31K |
| 2026-03-24 | Heath H Galloway | EVP,General Counsel & CorpSecy | F | −9,347 | −$18.97K |
| 2026-03-10 | Jonathan A Leon | EVP & CFO | A | +85,067 | — |
| 2026-03-10 | Perry A Bernocchi | EVP, Chief Operating Officer | A | +108,696 | — |
| 2026-03-10 | Heath H Galloway | EVP,General Counsel & CorpSecy | A | +61,437 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Edward A Pesicka | President & CEO | 1,072,785 | $213.59K |
| Kenneth Gardner-Smith | President & CEO | 369,667 | $73.60K |
| Perry A Bernocchi | EVP, Chief Operating Officer | 313,913 | $62.50K |
| Jonathan A Leon | EVP & CFO | 286,268 | $57.00K |
| Heath H Galloway | EVP,General Counsel & CorpSecy | 166,306 | $33.11K |
| Stephen W Klemash | Director | 90,242 | $17.97K |
| Teresa L. Kline | Director | 85,316 | $16.99K |
| Mark A Beck | Director | 71,259 | $14.19K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ACH quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.